Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

3.23
Delayed Data
As of Jul 02
 -0.02 / -0.62%
Today’s Change
1.00
Today|||52-Week Range
8.46
+26.67%
Year-to-Date

Today’s Trading

Previous close3.25
Today’s open3.68
Day’s range3.12 - 3.69
Volume7,422,433
Average volume (3 months)1,436,517
Market cap$235.7M
Dividend yield--
Data as of 4:00pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-15.15%
Earnings growth (this year)+29.32%
Earnings growth (next 5 years)--
Revenue growth (last year)-27.93%
P/E ratioNM
Price/Sales27.35
Price/Book15.47

Competitors

 Today’s
change
Today’s
% change
MSLIMerus Labs Internati...-0.16-6.43%
NVLSNivalis Therapeutics...+0.15+0.94%
TRVNTrevena Inc-0.06-0.99%
VVUSVIVUS Inc-0.01-0.43%
Data as of 4:00pm ET, 07/02/2015

Financials

Next reporting dateAugust 13, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$5.7M
Annual profit (last year)-$43.0M
Net profit margin-749.95%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel N. Swisher
CFO, Secretary &
EVP-Corporate Development
Eric H. Bjerkholt
Corporate headquarters
South San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers